Mitsubishi Ufj Trust & Banking Corp Novavax Inc Transaction History

Mitsubishi Ufj Trust & Banking Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$36.28 - $75.29 $1.24 Million - $2.57 Million	-34,105 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$69.73 - $142.9 $140,854 - $288,658	-2,020 Reduced 5.59%	34,105 $2.51 Million
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $560,038 - $907,191	-4,162 Reduced 10.33%	36,125 $5.17 Million
Q3 2021 Nov 12, 2021	SELL	$177.8 - $270.58 $46,939 - $71,433	-264 Reduced 0.65%	40,287 $8.35 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $4.91 Million - $10.4 Million	40,551 New	40,551 $8.61 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.